Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-12

Clinical Trial Update: Anticoagulation in ICH Survivors for Stroke Prevention and Recovery [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating anticoagulation in survivors of intracerebral hemorrhage with atrial fibrillation for stroke prevention and recovery is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: Intracerebral Hemorrhage, Atrial Fibrillation | Phase 3 | Status: RECRUITING